StockWatch
·
COROMANDEL INTERNATIONAL LTD. · QQ1 FY-2027 · THE CALL

Growth masks margin squeeze; subsidy revision now critical

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q1 FY27 resultsCOROMANDELCOROMANDEL INTERNATIONAL LTD.02 Aug 2026 · 6 min read
Verdict

Hold

confidence 7/10

Credibility

Grade B

Crop Protection guidance met (20% within 20-25% band). Subsidy revision—core assumption—not received. PAT significantly missed. Honest about constraints.

Short-term outlook

Cautiously Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Strong non-subsidy momentum (Crop Protection +20%, Retail +85%) overshadowed by 24% PAT collapse despite 16% revenue growth. Fertilizer margin compression is acute: production throttled to 72% capacity, EBITDA flat, subsidy revision remains pending. Backward integration investments (PA-SA, granulation) position long-term recovery, but near-term subsidy risk is material.

₹8164.8 Cr

Revenue · +15.9% YoY

₹381.6 Cr

Reported PAT · −23.9% YoY

Compressing

Margins · vs guidance: Mixed

Did the claims hold up?

Management's claims vs. the numbers

Fertilizer business delivered very strong numbers in spite of headwinds

OVERSTATED

Revenue +15.9%, but volumes down 9-10%, EBITDA flat ₹761Cr vs ₹782Cr, PAT -24%

Crop Protection delivered record performance, revenue up 20% to ₹870Cr, EBIT +44% to ₹159Cr

MET

Actual results match claim: ₹870Cr revenue, ₹159Cr EBIT confirmed in numbers

Industry maintained consumption sales volume of phosphatic fertilizer in Q1 vs last year despite subsidy lag

MET

Consumption was stable, farmers picked lower MRP stocks early; point-of-sales up 13% to 7.9L tons

Backward integration will drive EBITDA per ton from INR5,000 to INR6,500 once normalized

MISS

Q1 shows margin compression, not expansion. Target is aspirational; depends on subsidy revision & input price normalization not yet delivered

Earnings quality

What changed since the last call

Deltas vs. the prior call

Subsidy gap widened

Downgrade

Prior call: '10% subsidy increase'. Q1 reality: rates announced without Middle East crisis factoring. NP/NPK rates do not fully compensate for ammonia, sulphur spikes. Industry production/imports down 21%/38%.

Raw material inflation accelerating

Downgrade

Prior call: uncertainty on raw material trends. Q1 reality: ammonia/sulphur remain elevated. Phosphoric acid settled Q2 @ $1,700 vs $1,360 Q1 (+25%). Management expects sulphur to stay high 'for some time'.

Crop Protection momentum stronger

Upgrade

Prior call: optimism on exports. Q1 reality: +20% revenue to ₹870Cr, EBIT +44% to ₹159Cr. Strong pricing power vs cost inflation; product mix improved.

Backward integration tracking

Neutral

PA-SA plants commissioned as planned; operations stabilized. Rock phosphate mining (Senegal) producing 1.1L tons (on plan). Granulation on track for Q4. EBITDA/ton uplift deferred to normalized cost environment.

The Q&A

Analysts pressed hard on subsidy adequacy, margin defense, and capex ROI. Management held firm that subsidy revision is policy obligation; resisted cries of demand destruction. Defended capacity moderation as prudent amid high costs. Honest about leverage between pricing actions (already done) and subsidy dependency. Q&A quality: directional but hedged on timelines.

The exchanges that mattered

On-ground demand, subsidy gap — Ankur Periwal, Axis Capital

Answered

No shortage. Farmers picked up low MRP packs early season; slowdown in monsoon caused slowdown in purchase. Industry taken price actions; subsidy revision now needed to sustain production.

Subsidy revision timeline for Kharif — Ankur Periwal, Axis Capital

Partial

Industry taken max price actions. Beyond that, subsidy revision required. Represented to govt; hopeful outcome coming.

Crop Protection export traction — Ankur Periwal, Axis Capital

Answered

3-4 new 9(3) products yearly; 3-4 year pipeline visibility. Latin America presence light now; post-project, plan volume increase via combination products and on-ground presence.

Capital allocation: CDMO vs fertilizer backward integration — Ankur Periwal, Axis Capital

Answered

Separate tracks. PA-SA commission handles 60% acid need, comfortable on imports. CDMO organic path via launch plant at Ankleshwar; focus on fluorination for agrochemicals first, then scale to other sectors.

Forex contribution to Crop Protection EBITDA — Himani, ICICI Prudential

Answered

Follow netting principle, net exposure basis. No more than 5-6% of overall EBITDA attributable to forex.

NACL shareholding increase — Himani, ICICI Prudential

Dodged

I wish we can do that.

Capital allocation post PA-SA commissioning — Somaiah, Avendus Spark

Answered

Completing investments, want cash generation first. 8-9M tons nutrient capacity visibility for 2 years ahead. Evaluating MAP plant (Kakinada), purified phos acid for battery chemicals. Fertilizer capex deferred; land acquisition ongoing with Andhra Pradesh govt.

NACL margin trajectory — Somaiah, Avendus Spark

Answered

Current portfolio reached reasonable EBITDA level. Moving from 3-4% to 7-8% to 10-11% stages. Further upside requires new products (2-3 year lag). Pursuing intermediates, CDMO to improve margins beyond efficiency gains.

CPC revenue divergence: Coromandel vs NACL — Somaiah, Avendus Spark

Answered

NACL molecules saw price moderation to global MNCs. Coromandel ability to pass through higher input costs realized better pricing. Reflects product mix difference between two entities.

Sulphur price sustainability — Somaiah, Avendus Spark

Answered

Against expectations, holding high. Likely remain high 'some time' but not sustainable. EV battery demand (nickel leaching) structural shift. These exorbitant levels should soften but may take while. Decided to stay out at these prices; doesn't make economic sense.

Capex target for next 1-2 years — Vivek, DSP Mutual Funds

Answered

Things change; focused on realizing value from INR7,000Cr invested last 3-4 years. Normal sustainable capex INR300Cr annually, but opportunities-based.

NPK to DAP farmer preference shift — Riju, Antique Stock Broking

Answered

No shift happening. DAP high-P (INR1,350/bag) vs 20:20 low-P (INR2,100) doesn't reflect balanced nutrition. If subsidy not corrected for NPK, could have demand destruction risk. Current artificial pricing also impacting. DAP not available beyond volumes; govt encouraging alternates like SSP, organic.

BMCC ramp-up and depreciation spike — Riju, Antique Stock Broking

Answered

Consolidated depreciation includes mining amortization (overfurden). PA-SA capex depreciation ~INR16-18Cr, NACL intangible amortization ~INR20-21Cr, mining charges ~INR30Cr. Not due to capex alone; mainly mining/amortization expenses.

CP export/domestic mix — Riju, Antique Stock Broking

Partial

Will get back to you on specifics.

QR code traceability framework impact — Ranjit, IIFL

Answered

Witnessed pilot in retail store. QR code links farmer to farm holding/crop type; recommends Urea/DAP/NPK dosage to retailer POS. Farmer restricted to prescribed bags. Win-win: reduces govt subsidy, farmer ensures no N overuse, removes channel arbitrage. Pilot in 10-12 states, 2-3 districts each (Telangana, Karnataka major districts).

EBITDA bridge: consol vs standalone gap — Ranjit, IIFL

Answered

BMCC mining costs amortized below EBITDA in depreciation line. So consolidated EBITDA shows mining profit, but after amortization, net impact ~INR30Cr. This gap primarily from BMCC.

Request for subsidy/non-subsidy EBITDA split — Ranjit, IIFL

Partial

Should do that definitely. Will try to put those in.

Pricing actions taken vs remaining correction needed — Tarang, Old Bridge

Answered

25-30% price increase already done across grades this year. Beyond this, impossible; has to come from subsidy. Global raw materials correcting slightly (urea $900→down, ammonia softening, sulphur coming off), but industry calibrated purchases to avoid high-cost carryover. Further price increase not doable.

CP revenue growth drivers amid soft market — Tarang, Old Bridge

Answered

Global agri commodity prices softening, farmer affordability down, cheaper alternatives sought, specialties pushed back. Certain molecules Coromandel deals in not from China; China keeps AIs low, intermediates high. Some markets can absorb price increases. Focusing on B2B exports now; aiming B2C via brands & combinations long-term. AI prices better than earlier.

NPK production decline and subsidy dependency — Dhruv, HDFC AMC

Answered

100%. Otherwise doesn't make economic sense for production. Domestic capacities cannot afford to produce at high sulphur/ammonia prices. Critical for subsidy rates to get revised; else production impact Q2 as well.

Nano DAP adoption and regulatory bans — Dhruv, HDFC AMC

Answered

Ideally yes, but UP and Maharashtra state bans put hold on demand. Without bans, volumes would pick up significantly. Good global response; started exports last quarter. Coming quarters will focus on international Nano business once registrations complete. Nano DAP working well, confident in product.

Subsidy adequacy vs industry cost base — Prashant, Elara Capital

Partial

Let subsidy come then derive EBITDA per ton. Seeking 6-month average rate per policy, not ad-hoc. No plant can sustain this cost increase in global environment without policy-defined average.

QR code impact on balanced nutrition demand — Prashant, Elara Capital

Answered

Urea and DAP will be curtailed under QR framework. Ideally should increase NP/NPK demand (better balanced nutrition), but not yet happening at scale.

CP expansion and capacity utilization — Prashant, Elara Capital

Answered

Just completing capacity expansion. Want to focus on cash generation. Won't add AI capacities (spare in NACL available); leverage capacity between both plants. Investment more toward marketing, brand building, channel network vs asset creation.

BMCC capex and SSP facility plans — Prashant, Elara Capital

Answered

Operating plant at target 5L tons rock phosphate production per plan. Want to invest in SSP facility (doesn't cost much $5-6M for 100-150K tons). Huge opportunity using reject rocks; adds value on phosphate in Senegal, can export regionally. If successful at smaller scale, may expand to capture more value in Senegal.

Subsidy delay causes — Darshita Shah, DSP Asset Managers

Answered

Pressure on overall subsidy bill across categories. Govt cost-passes Urea fully (higher gas prices), DAP compensated fully. Pushback on NP/NPK due to budget constraints. Industry represented; awaiting outcome.

New market entry strategy post granulation — Darshita Shah, DSP Asset Managers

Answered

Capacity 750K tons. Want to sell 50% via retail outlets (increasing footprint Maharashtra, Tamil Nadu, Andhra Pradesh, Telangana). Balance 50% (350-400K tons) seeding markets UP, Rajasthan, MP, Chhattisgarh. No challenge in absorbing additional volume.

Subsidy as policy vs ad-hoc support — Naushad Chaudhary, Aditya Birla Mutual Fund

Answered

Seeking policy-defined 6-month average rate for NBS, not ad-hoc subsidy like DAP/Urea. NP/NPK predominantly produced in India. Not asking for additional support; seeking what policy defines.

Capex ROI and EBITDA per ton uplift — Nirav, Anvil Wealth

Answered

Average EBITDA per ton needs to go from INR5,000 to INR6,500. Rest of capex toward Senegal or CP new capacity. CP margins show payback <3 years on some capex.

Specialty Nutrients contribution to FY26 EBITDA — Nirav, Anvil Wealth

Answered

No separate number provided. Continuously growing topline 25-30%, EBITDA margin 20%. Sulphur expansion not helped yet due to current situation (temporary). Pursuing MAP plant, seaweed/gypsum granulation. Business growing well.

SSP business per-ton contribution — Nirav, Anvil Wealth

Answered

INR2,500 to INR3,000 per ton.

Dhaksha drone subsidiary performance — Vipulkumar, Sumangal Investment

Answered

Focusing agri drones, gained good traction. Coromandel purchased 100-150 drones Q1, plan 500-drone fleet during year. Dhaksha will cater to agri-drones. Defense orders in final stage; once materialize, scale up. Not very significant EBITDA drag currently.

NPK EBITDA per ton target — Vipulkumar, Sumangal Investment

Answered

Yes, once commercialize plant in steady state in normal situation. Don't expect this quarter (spurt in input prices). Once normalcy restores, should realize it.

Optimal sulphur price for backward integration viability — Sandeep Mukherjee, SKP Securities

Answered

Given phosphoric acid at $1,700, at least want $800 sulphur pricing.

Guidance

Forward guidance and management's confidence

Capacity visibility: 8-9M tons nutrients + 1M tons trading (DAP) over next 2 years

High

Post PA-SA/granulation commissioning. Excludes unforeseen subsidy/geopolitical shocks. Includes fertilizer + SSP + organic + Urea + imported DAP.

Crop Protection: Latin America expansion via Mancozeb combination products & on-ground presence post capex

Medium

Timeline: 2-3 year horizon. Dependent on successful molecule positioning and MNC partnerships (CDMO strategy underway).

Retail: 50% of 750K ton capacity via own outlets (maximizing existing markets); 50% via wholesale in UP, Raj, MP, CG

High

Market seeding already underway. No absorption challenge flagged. Organic network expansion model (low capex).

Fertilizer EBITDA per ton: INR5,000 → INR6,500 (30% uplift) via backward integration (PA-SA acid security + imported cost arbitrage)

Low

Dependent on subsidy rate normalization and input cost stabilization. Q1 shows compression, not expansion. Management cautious: 'don't ask for this quarter; normal situation required'.

Crop Protection: <3 year capex payback on select investments; improved product mix & pricing power sustaining 40%+ EBIT growth

Medium

Contingent on continued export momentum and ability to pass-through raw material inflation (demonstrated Q1).

Specialty Nutrients: 25-30% topline growth, 20% EBITDA margin (structural level). Sulphur expansion underutilized temporarily

Medium

Dependent on farmer adoption of water-soluble grades (drip irrigation uptake) and premium product mix (granulation launches).

Sustainable annual capex: INR300Cr run-rate post-completion of PA-SA/granulation/capacity expansion projects

High

Maintenance + selective opportunities. Last 3-4 years invested INR7,000Cr (organic + NACL inorganic); focus now on cash generation from these assets.

Senegal SSP facility: $5-6M capex for 100-150K ton capacity; scaling dependent on success at smaller pilot level

Medium

Strategic to utilize reject rocks and capture value addition in Senegal. Decision point tied to pilot results.

MAP plant (Kakinada): To come up after 1 year or so for raw material security + trading opportunity in specialty nutrients

Medium

Timing flexible; dependent on market conditions and internal cash generation priorities.

Risks the call surfaced

Ranked by how much they should concern a holder

Subsidy-Margin Misalignment

High

Government NBS subsidy rates (10% increase announced) do not factor Middle East crisis raw material inflation (ammonia, sulphur). NP/NPK rates inadequate; management seeking 6-month average per policy but revision pending. Without revision, fertilizer EBITDA unsustainable; further production cuts likely.

Raw Material Inflation

High

Sulphur, ammonia, phosphoric acid prices elevated due to West Asia geopolitical disruptions and supply cuts by major manufacturers. Phosphoric acid Q2 settled at $1,700 (vs $1,360 Q1, +25%). Sulphur expected to remain high 'for some time.' Price pass-through limited by subsidy cap and farmer affordability.

Volume/Demand Elasticity

Medium

Fertilizer sales volumes moderated 9-10% Q1 despite company market share gains (22% primary vs 18%). Production throttled to 72% capacity utilization. Risk: if subsidy not revised and prices further hiked, demand destruction among price-sensitive farmers; could exceed current 10% volume decline.

Monsoon Dependency

Medium

India experienced 23% deficit rainfall (long-period average) in Q1. Reservoir levels 34% of capacity vs 57% prior year. While sowing improved in July (deficit moderated to 17%), continued drought risk could dampen kharif demand and fertilizer offtake in Q2.

Regulatory/State Bans

Low

Nano DAP and Nano Urea banned by state governments in UP and Maharashtra (major agricultural states). Constrains adoption of these alternate fertilizers despite strong farmer response and subsidy cost-saving potential. Risk: further state-level bans or delayed approval could cap Nano category growth.

Management

Score 7/10. Transparent on constraints (subsidy lag, raw material inflation). Repeated subsidy dependency theme; honest about limited pricing room. Some hedging on subsidy revision certainty ('hopeful'). Technical depth strong (cost breakdowns, capacity planning). Avoids hype; grounded in numbers. PA-SA/granulation projects tracking as planned (positive track record). NACL integration progressing to target margins (positive). But PAT down 23.9% despite prior confidence in 'resilient performance'—disconnect between narrative and delivery on profitability.

What to watch next
  • 1 · Aug-Sep 2026

    Kharif subsidy revision announcement; phosphoric acid Q2 @ $1,700 vs $1,360 Q1

  • 2 · Q4 FY27

    Granulation project commissioning; capacity headroom for fertilizer volumes

  • 3 · FY27-FY28

    Sulphuric acid plant ramp-up; backward integration margin bridge to INR6,500/ton

Backward integration investments (PA-SA, granulation) position long-term recovery, but near-term subsidy risk is material.

Informational and educational content only. Not investment advice.

Growth masks margin squeeze; subsidy revision now critical — StockWatch